Autopsy report · NCT03420976

Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth

“PI no longer in practice.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

Atrium Innovations

Sponsor type

Industry

Conditions

Small Intestinal Bacterial Overgrowth

Interventions

Novel Supplement Based Therapy

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine
  “PI is no longer here.” (83% match in meaning)
• Sensory Habituation in Autism Spectrum Disorders
  “PI no longer at institution.” (77% match in meaning)
• Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation
  “PI no longer at this facility” (73% match in meaning)
• Treatment of Chorioamnionitis After Delivery
  “PI retired” (72% match in meaning)
• Cross-sectional Study on a Given Day Within the Paris Saint-Joseph Hospital Group
  “The PI decided it.” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.